Because infectious disease research deals with a wide range of viral, bacterial, and fungal pathogens, it demands analytical instruments that are precise but also versatile. Count on our in vivo, in situ, cellular and biochemical research products for infectious disease detection and biomarker quantitation.
Our products for infectious disease research include:
- LANCE? TR-FRET biomarker detection technology
- AlphaLISA? Immunoassay kits
- DELFIA? (dissociation-enhanced lanthanide fluorescence immunoassay) TRF ELISA alternative technology
- Cellular and in vivo imaging systems
- Bioluminescent bacterial strains
This product portfolio meets the needs of many applications for infectious disease detection and research:
- Detection of bacterial infections (including E. coli), viral infections (including Coronavirus, Zika, Hepatitis B and C, Epstein-Barr, HIV, and H1N1), and of fungal infections
- Quick quantitation of biomarkers for infectious disease and pathogenesis in human and plant samples, including p24 and p27 viral proteins
- Monitoring acute and chronic infection and therapeutic treatment in animal models in real time
- Quantitative assessment and growth inhibition with our gram negative and gram positive bacteria labeled with luciferase
- Phenotypic analysis